Microfractionation revisited: a 1536 well high resolution screening assay.

The aim of the here presented study was to combine high performance liquid chromatography with plate reader technology in order to overcome certain drawbacks of integrated online systems as well as offline plate reader approaches. The described method combines an "at-line" enzyme assay for the simultaneous bioactivity determination with parallel QTOF MS data acquisition for analyte identification. All biochemical reagents are added in an online mode directly to the column effluent (postcolumn addition/mixing), and the complete screening assay mixture is subsequently microfractionated into a 1536 well plate. The screening of a natural extract fortified with two well-known Protein Kinase A inhibitors and the identification of an inhibitor in a natural extract showed the applicability of the approach to detect bioactive compounds in low concentrations in a complex mixture. The described mode of operation utilizes today's plate reader technology to its full capacity and directly hyphenates it to a high resolution separation technique which has not been shown before. Furthermore, it allows coupling of a microbore HPLC with a biochemical screening assay without compromising resolution and overcomes problems associated with the 1536 well format.

[1]  H. Irth.  Continuous‐Flow Systems for Ligand Binding and Enzyme Inhibition Assays Based on Mass Spectrometry , 2007 .

[2]  M. Hagiwara,et al.  Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. , 1988, Biochemical pharmacology.

[3]  R. Colombo,et al.  HPLC microfractionation of flavones and antioxidant (radical scavenging) activity of Saccharum officinarum L. , 2008 .

[4]  B. Blazics,et al.  Polyphenol composition and antioxidant capacity of Epilobium species. , 2009, Journal of pharmaceutical and biomedical analysis.

[5]  P. Vuorela,et al.  Linarin, a selective acetylcholinesterase inhibitor from Mentha arvensis. , 2006, Fitoterapia.

[6]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[7]  Jean-Luc Wolfender,et al.  Phytochemistry in the microgram domain—a LC–NMR perspective , 2005, Magnetic resonance in chemistry : MRC.

[8]  Uwe Karst,et al.  Development of a countergradient parking system for gradient liquid chromatography with online biochemical detection of serine protease inhibitors. , 2008, Analytical chemistry.

[9]  Harren Jhoti,et al.  High-throughput crystallography for lead discovery in drug design , 2002, Nature Reviews Drug Discovery.

[10]  C. Schmitz‐Peiffer,et al.  Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. , 1990, The Biochemical journal.

[11]  Johannes Ottl,et al.  Readout Technologies for Highly Miniaturized Kinase Assays Applicable to High-Throughput Screening in a 1536-Well Format , 2006, Journal of biomolecular screening.

[12]  Alan L Harvey,et al.  Natural products as a screening resource. , 2007, Current opinion in chemical biology.

[13]  E. Bissonette,et al.  Activated 3′,5′-Cyclic AMP-dependent Protein Kinase Is Sufficient to Induce Neuroendocrine-like Differentiation of the LNCaP Prostate Tumor Cell Line* , 2000, The Journal of Biological Chemistry.

[14]  Mary Kay Harper,et al.  Fractionated Marine Invertebrate Extract Libraries for Drug Discovery , 2008, Molecules.

[15]  D. Fabbro,et al.  Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. , 1995, European journal of biochemistry.

[16]  P. Vuorela,et al.  HPLC micro-fractionation coupled to a cell-based assay for automated on-line primary screening of calcium antagonistic components in plant extracts , 2004, Analytical and bioanalytical chemistry.

[17]  H. Lingeman,et al.  Systematic development of an enzymatic phosphorylation assay compatible with mass spectrometric detection , 2005, Analytical and bioanalytical chemistry.

[18]  C. V. Van Pelt,et al.  Ultralow-volume fraction collection from NanoLC columns for mass spectrometric analysis of protein phosphorylation and glycosylation. , 2006, Analytical chemistry.

[19]  F. Koehn,et al.  The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.

[20]  Ralf Thiericke,et al.  Evaluation of Liquid Handling Conditions in Microplates , 2001, Journal of biomolecular screening.

[21]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[22]  H. Cheng,et al.  Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. , 1989, The Journal of biological chemistry.

[23]  P. Broad,et al.  Identification of kinase inhibitors by an ATP depletion method. , 2004, Assay and drug development technologies.

[24]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[25]  K. Hostettmann,et al.  On-line identification of the bioactive compounds from Blumea gariepina by HPLC-UV-MS and HPLC-UV-NMR, combined with HPLC-micro-fractionation. , 2005, Phytochemical analysis : PCA.